Brief: PYC Therapeutics Seeks Trading Halt
21/10/2024 01:45
Oct 21 (Reuters) - PYC Therapeutics Ltd PYC.AX :
* TRADING HALT REQUESTED PENDING ANNOUNCEMENT ON RETINITIS
PIGMENTOSA TRIALS
Source text for Eikon: ID:nASX2RQhfG
Further company coverage: PYC.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on PYC Therapeutics
See all newsAustralia's PYC Therapeutics rises on EU orphan drug status
Brief: PYC Therapeutics Posts HY Revenues From Ordinary Activities A$11.0 Million
Brief: PYC Therapeutics Announces Raising Up To A$653 Million
Brief: PYC Therapeutics Seeks Trading Halt
Brief: PYC Therapeutics Says Rohan Hockings Re-Appointed As Managing Director